tiprankstipranks
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
NRIX
Nurix Therapeutics
RESEARCH TOOLSreports
Want to see NRIX full AI Analyst Report?

Nurix Therapeutics (NRIX) Stock News & Sentiment

574 Followers
Analyst Reiterates Buy on Nurix, Maintains $32 Price Target on Strength of Degrader Platform and Pipeline
Premium
Ratings
Analyst Reiterates Buy on Nurix, Maintains $32 Price Target on Strength of Degrader Platform and Pipeline
8d ago
NRIX
Buy Rating on Nurix Therapeutics Backed by Strong Clinical Momentum, Strategic Execution, and Attractive Risk‑Reward Profile
Premium
Ratings
Buy Rating on Nurix Therapeutics Backed by Strong Clinical Momentum, Strategic Execution, and Attractive Risk‑Reward Profile
21d ago
NRIX
Nurix Therapeutics: Buy Rating Backed by Advancing Bexobrutideg Program, Sanofi STAT6 Milestones, and Solid Cash Runway
Premium
Ratings
Nurix Therapeutics: Buy Rating Backed by Advancing Bexobrutideg Program, Sanofi STAT6 Milestones, and Solid Cash Runway
27d ago
NRIX
Nurix Advances NX-5948 Into Phase 3 Head-to-Head Battle in CLL/SLL
Premium
Company Announcements
Nurix Advances NX-5948 Into Phase 3 Head-to-Head Battle in CLL/SLL
27d ago
NRIX
Nurix Therapeutics Expands ATM Equity Offering Capacity
Premium
Company Announcements
Nurix Therapeutics Expands ATM Equity Offering Capacity
2M ago
8K
NRIX
Nurix Therapeutics Exposed to Significant Foreign Exchange Risk Amid Unhedged Currency Exposure
Premium
Company Announcements
Nurix Therapeutics Exposed to Significant Foreign Exchange Risk Amid Unhedged Currency Exposure
3M ago
NRIX
3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
3M ago
CRVS
NRIX
More NRIX News >

NRIX News on the Web

Buy Rating on Nurix Therapeutics Backed by Strong Clinical Momentum, Strategic Execution, and Attractive Risk‑Reward Profile
TipRanks News
Bullish
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?
Zacks
Bullish
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Neogen (NEOG) and Nyxoah (NYXH)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Nurix Therapeutics (NRIX)
TipRanks News
Bullish
Company News for Apr 9, 2026
Zacks
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Inovio Pharmaceuticals (INO), Elevance Health (ELV)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Nurix Therapeutics (NRIX)
TipRanks News
Bullish
Nurix Therapeutics price target lowered to $28 from $29 at Wells Fargo
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
NRIX
Sector Average
Media Buzz
This Week1 articles
Weekly Average6.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NRIX’s Media Buzz Sentiment?
1 articles about NRIX were published this week. In an average week, 6.25 articles are published.
    What is NRIX’s weekly average amount of articles?
    In an average week, 6.25 articles about NRIX are published.
      What is NRIX’s News Sentiment?
      100% of articles about NRIX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week